Lexicon Pharmaceuticals
LXRX
#6861
Rank
C$0.97 B
Marketcap
C$2.19
Share price
-8.38%
Change (1 day)
7.37%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): C-$0.20

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$0.20. In 2025 the company made an earnings per share (EPS) of C-$0.20 an increase over its 2024 EPS that were of C-$0.92.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.20-1.91%
2025C-$0.20-78.13%
2024C-$0.92-20%
2023C-$1.1531.15%
2022C-$0.87-0%
2021C-$0.8710.91%
2020C-$0.79-145.08%
2019C$1.75-206.09%
2018C-$1.65-5.74%
2017C-$1.75-10.95%
2016C-$1.962640%
2015C-$0.07169-96.34%
2014C-$1.96-2.53%
2013C-$2.01-9.09%
2012C-$2.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$27.23-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$8.45-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$67.36-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$7.44 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.71-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02868-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.08 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C-$0.13-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$42.00 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA